BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33859741)

  • 1. Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis.
    Wang T; Chen L; Chikkanna A; Chen S; Brusius I; Sbuh N; Veedu RN
    Theranostics; 2021; 11(11):5174-5196. PubMed ID: 33859741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of aptamers as molecular recognition elements in lateral flow assays.
    Reid R; Chatterjee B; Das SJ; Ghosh S; Sharma TK
    Anal Biochem; 2020 Mar; 593():113574. PubMed ID: 31911046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptamer-based lateral flow assay on-site biosensors.
    Huang L; Tian S; Zhao W; Liu K; Ma X; Guo J
    Biosens Bioelectron; 2021 Aug; 186():113279. PubMed ID: 33979718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent developments of aptamer-based lateral flow assays for point-of-care (POC) diagnostics.
    Jaisankar A; Krishnan S; Rangasamy L
    Anal Biochem; 2022 Oct; 655():114874. PubMed ID: 36027971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer lateral flow assays for rapid and sensitive detection of cholera toxin.
    Frohnmeyer E; Tuschel N; Sitz T; Hermann C; Dahl GT; Schulz F; Baeumner AJ; Fischer M
    Analyst; 2019 Feb; 144(5):1840-1849. PubMed ID: 30681077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasensitive and Highly Specific Lateral Flow Assays for Point-of-Care Diagnosis.
    Liu Y; Zhan L; Qin Z; Sackrison J; Bischof JC
    ACS Nano; 2021 Mar; 15(3):3593-3611. PubMed ID: 33607867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule detection with aptamer based lateral flow assays: Applying aptamer-C-reactive protein cross-recognition for ampicillin detection.
    Kaiser L; Weisser J; Kohl M; Deigner HP
    Sci Rep; 2018 Apr; 8(1):5628. PubMed ID: 29618771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer-Based Lateral Flow Assays: Current Trends in Clinical Diagnostic Rapid Tests.
    Majdinasab M; Badea M; Marty JL
    Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Six Aptamer-Aptamer Pairs on Rapid Detection of SARS-CoV-2 by Lateral Flow Assay.
    Çam Derin D; Gültekin E; Gündüz E; Otlu B
    J AOAC Int; 2024 May; 107(3):464-470. PubMed ID: 38218729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replacing antibodies with aptamers in lateral flow immunoassay.
    Chen A; Yang S
    Biosens Bioelectron; 2015 Sep; 71():230-242. PubMed ID: 25912679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral and Vertical Flow Assays for Point-of-Care Diagnostics.
    Jiang N; Ahmed R; Damayantharan M; Ünal B; Butt H; Yetisen AK
    Adv Healthc Mater; 2019 Jul; 8(14):e1900244. PubMed ID: 31081270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and optimizing gold nanoparticle-cDNA nanoprobes for aptamer-based lateral flow assay: Application to rapid detection of acetamiprid.
    Mao M; Xie Z; Ma P; Peng C; Wang Z; Wei X; Liu G
    Biosens Bioelectron; 2022 Jul; 207():114114. PubMed ID: 35279637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A portable and universal upconversion nanoparticle-based lateral flow assay platform for point-of-care testing.
    Gong Y; Zheng Y; Jin B; You M; Wang J; Li X; Lin M; Xu F; Li F
    Talanta; 2019 Aug; 201():126-133. PubMed ID: 31122402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview for the Nanoparticles-Based Quantitative Lateral Flow Assay.
    Wang Z; Zhao J; Xu X; Guo L; Xu L; Sun M; Hu S; Kuang H; Xu C; Li A
    Small Methods; 2022 Jan; 6(1):e2101143. PubMed ID: 35041285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold nanoparticle-streptavidin conjugates for rapid and efficient screening of aptamer function in lateral flow sensors using novel CD4-binding aptamers identified through Crossover-SELEX.
    Fellows T; Ho L; Flanagan S; Fogel R; Ojo D; Limson J
    Analyst; 2020 Aug; 145(15):5180-5193. PubMed ID: 32567629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integrated lateral flow assay for effective DNA amplification and detection at the point of care.
    Choi JR; Hu J; Gong Y; Feng S; Wan Abas WA; Pingguan-Murphy B; Xu F
    Analyst; 2016 May; 141(10):2930-9. PubMed ID: 27010033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Lock-and-key" recognizer-encoded lateral flow assays toward foodborne pathogen detection: An overview of their fundamentals and recent advances.
    Liu X; Kukkar D; Deng Z; Yang D; Wang J; Kim KH; Zhang D
    Biosens Bioelectron; 2023 Sep; 235():115317. PubMed ID: 37236010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral flow assays (LFA) for detection of pathogenic bacteria: A small point-of-care platform for diagnosis of human infectious diseases.
    Sohrabi H; Majidi MR; Fakhraei M; Jahanban-Esfahlan A; Hejazi M; Oroojalian F; Baradaran B; Tohidast M; Guardia M; Mokhtarzadeh A
    Talanta; 2022 Jun; 243():123330. PubMed ID: 35272153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QDs-based fluorescent lateral flow assays for Point-of-care testing of insulin.
    Kaur J; Deng F; Morris MJ; Goldys E
    Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38082853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lateral flow assays for hormone detection.
    Khelifa L; Hu Y; Jiang N; Yetisen AK
    Lab Chip; 2022 Jun; 22(13):2451-2475. PubMed ID: 35713489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.